Singapore markets closed

Longeveron Inc. (LGVN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.7500-0.0600 (-3.31%)
At close: 04:00PM EDT
1.7700 +0.02 (+1.14%)
After hours: 07:39PM EDT
Full screen
Loading interactive chart…
  • GlobeNewswire

    Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

    MIAMI, May 02, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will report first quarter 2024 financial results and provide a business update on Tuesday, May 14, 2024 after the U.S. financial markets close. The Company will host a conference call and webcast the same day at 5:00 p.m. ET. Conference Call Details: Conference Call Number: 1.877.407.0789 Conference ID: 13745868 Call meTM Featur

  • GlobeNewswire

    Longeveron to Present at the Planet MicroCap Showcase

    MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will participate in the Planet MicroCap Showcase, taking place May 1-2, 2024. Details for the Company’s presentation: Date:Wednesday, May 1, 2024 Time:4:30 p.m. PT Webcast:Click Here An archived replay of the webcast will be available on the “Events & Presentations” section of the Company’s website following the conference. If

  • GlobeNewswire

    Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering

    MIAMI, April 18, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, today announced the closing of its previously announced exercise of certain existing warrants to purchase an aggregate of 2,399,744 shares of its Class A common stock havin